Two more HIV protease inhibitors approved.
J L
JL
Fox
D019380:Anti-HIV Agents / Q000627:therapeutic use; D001709:Biotechnology; D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir; D019438:Ritonavir